T. Abe

Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer.

R. Kanamaru, C. Ishioka, H. Kikuchi, 1992, The Tohoku journal of experimental medicine.

Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer

R. Kanamaru, H. Kikuchi, I. Sagami, 1991, Japanese journal of cancer research : Gann.

MspI polymorphism of the human CYP2E gene.

H. Kikuchi, I. Sagami, M. Motomiya, 1991, Nucleic acids research.

Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure.

R. Kanamaru, S. Ikawa, H. Kikuchi, 1994, Pharmacogenetics.

Genetic differences in the induction of aryl hydrocarbon hydroxylase and its components by 3-methylcholanthrene in liver and lung microsomes among four strains of guinea pigs.

T. Abe, M. Watanabe, 1982, Biochemical pharmacology.

Purification and characterization of three forms of microsomal cytochrome P-450 in liver from 3-methylcholanthrene-treated guinea pigs.

T. Abe, M. Watanabe, 1983, Molecular pharmacology.

Partial purification of pulmonary cytochrome P-448 from 3-methylcholanthrene-treated rats.

T. Abe, M. Watanabe, Y. Tamura, 1981, The Journal of toxicological sciences.

Antitumor activity of cyclophosphamide and lipopolysaccharide in tumor-bearing mice pretreated with BCG.

K. Konno, M. Motomiya, H. Sato, 1987, The Tohoku journal of experimental medicine.